Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Caplin Point Laboratories Ltd.
NSE: CAPLIPOINT
|
BSE: 524742
|
ISIN: INE475E01026
|
Industry: Pharmaceuticals
US FDA Approval
|
Falling Comet
1727.0000
14.40
(
0.84
%)
NSE
Feb 25, 2026
15:31 PM
27.89% Fall from 52W High
Volume:
21,410
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Caplin Point Laboratories Ltd.
13 May 2022
US FDA Approval
1727.00
0.84%
Caplin Point Laboratories
Buy:
Caplin Point Laboratories ...
by
ICICI Direct
Target: 895
ICICI Direct
Caplin Point Labs has lost
-20.35%
in the last 6 Months
More from Caplin Point Laboratories Ltd.
Recommended
Market closes higher, supported by a rebound in IT stocks & positive global cues
Trendlyne Marketwatch |
25 Feb 2026, 03:57PM
Five stocks to buy from analysts this week - February 24, 2026
The Baseline |
24 Feb 2026, 06:01PM
Caplin Point Laboratories maintains export momentum, expands ambitions to new markets
|
01 Jul 2022